The medicine "Trimetazidine" is considered quite effective. This is indicated by the reviews of many patients. Often the drug "Trimetazidine" is prescribed for heart disease. Its analogues include such medicines as Angiosil, Deprenorm, Carditrim and others.
The antianginal agent "Trimetazidine" (instructions for use indicates this) provides myocardial cells with constant protection against ischemia. The medication is available in the form of slow release tablets. The active substance of the drug is trimetazadine.
The medication has an antihypoxic effect.
The tool provides the normalization of energy metabolism of cells undergoing ischemia or hypoxia, prevents a decrease in ATP content.
Taking the drug "Trimetazidine" with angina pectoris reduces the frequency of seizures, increases the tolerance of physical activity. The medication helps to reduce the need for nitrates. In the course of studies it was found that taking the drug "Trimetazidine" helps to increase the coronary reserve, thus slowing down the development of ischemia provoked by physical exertion. A persistent effect is noted from the fifteenth day of therapy. Means "Trimetazidine" (instructions for use contains such information) is able to limit sharp drops in blood pressure without significant changes in heart rate.
With chorioretinal ischemia, the medication helps to restore the activity of the retina. The drug has also been shown to be effective in hearing loss, vestibular disorders, and Meniere's disease.
The active substance is well absorbed from the digestive tract. Excretion is carried out quickly enough, mainly with urine.
The tool "Trimetazidine", the instructions for use recommends with prolonged treatment of coronary heart disease, as a prophylactic agent that prevents angina attacks. The medication is prescribed for disorders of the cochleo-vestibular nature of the ischemic nature associated with circulatory disorders of the brain. These include, in particular , Meniere's disease, tinnitus, and auditory dysfunctions. Means "Trimetazidine" instructions for use recommends for chorioretinal vascular disorders complicated by ischemia.
The recommended amount of medication per day is from forty to sixty milligrams. The drug is usually prescribed per day two to three times twenty milligrams or 1-2 times thirty-five. The medication is taken with food.
The duration of treatment is set in accordance with the course of the pathology and the condition of the patient.
In clinical practice, in compliance with the dosage regimen and the recommendations of the specialist for taking the medication "Trimetazidine" overdoses were not recorded.
The tool is not allowed to be taken with hypersensitivity.
Due to the lack of data on the effect of the drug "Trimetazidine" on the condition of the fetus, pregnant woman or newborn, the medication is not prescribed to patients during gestation and lactation.
Taking the drug can provoke allergies, epigastric pain, skin itching, and vomiting.
When prescribing the drug "Trimetazidine" in renal failure, it is necessary to regularly monitor the functional activity of the kidneys. If necessary, the dosage should be reduced.
The effect of the Trimetazidine medication on the ability to concentrate attention, drive a car and perform activities requiring a high speed of mental and motor reactions was not revealed.
The tool is not recommended after the expiration date indicated on the package.
Before using the medication "Trimetazidine", you should definitely study the annotation.